takeda pharmaceutical company

Takeda, Christophe Weber

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie Kim,

Bloomberg L.P. · 1d

Takeda Picks First Woman as CEO of Centuries-Old Drugmaker

Takeda Pharmaceutical Co.’s board has selected Julie Kim, the head of the company’s US unit, to replace Christophe Weber as the drugmaker’s new chief executive officer.

STAT · 20h

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price over the last couple of years.

Takeda Pharmaceutical Co.: Hold Rating Amid Mixed Q3 Results, Upward Guidance Revision, and Strategic Moves

Miki Sogi, an analyst from Bernstein, maintained the Hold rating on Takeda Pharmaceutical Co (TKPHF – Research Report). The associated price ...

12h

Takeda Prevails Over Sales Rep's Race, Disability Bias Claims

Takeda Pharmaceuticals America Inc. convinced a federal court to toss an employee’s claims that the company discriminated against her for being a White woman with depression and PTSD.

13h

Takeda Pharmaceutical Company Limited (TAK) Q3 2025 Earnings Call Transcript

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET Christopher O’Reilly - Head, Investor Relations Christophe Weber - President and Chief ...

22h

Takeda 9-Month EPS Rises, Revises FY24 Outlook, Julie Kim To Be New CEO

Concurrently, the company also announced the decision to appoint Julie Kim as the Chief Executive Officer, succeeding Christophe Weber, who plans to retire from the position in June 2026. Kim ...